Genetic generalized epilepsy and generalized onset seizures with focal evolution (GOFE).
Focal evolution
Generalized onset
Generalized onset seizures with focal evolution (GOFE)
Genetic Generalized Epilepsy (GGE)
Idiopathic Generalized Epilepsies (IGEs)
Seizure type
Journal
Epilepsy & behavior reports
ISSN: 2589-9864
Titre abrégé: Epilepsy Behav Rep
Pays: United States
ID NLM: 101750909
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
03
2022
revised:
24
05
2022
accepted:
28
05
2022
entrez:
16
6
2022
pubmed:
17
6
2022
medline:
17
6
2022
Statut:
epublish
Résumé
"Generalized Onset with Focal Evolution" (GOFE) is an underrecognized seizure type defined by an evolution from generalized onset to focal activity during the same ictal event. We aimed to discuss electroclinical aspects of GOFE and to emphasize its link with Genetic Generalized Epilepsy (GGE). Patients were identified retrospectively over 10 years, using the video-EEG data base from the Epilepsy Unit of Strasbourg University Hospital. GOFE was defined, as previously reported, from an EEG point of view with an evolution from generalized onset to focal activity during the same ictal event. Three male patients with GOFE were identified among 51 patients with recorded tonic-clonic seizures. Ages at onset of seizures were 13, 20 and 22 years. Focal clinical features (motor asymmetric phenomenology) could be identified. EEG showed generalized interictal discharges with focal evolution of various localization. Four seizures were recorded characterized by 2-3 s of generalized abnormalities followed by focal (parieto-occipital or frontal) discharges. There were initially uncontrolled seizures with lamotrigine, but all patients reported a good outcome with valproate monotherapy. We emphasize that GOFE presents many similarities with GGE. Recognition of the GOFE entity could bring a therapeutic interest avoiding misdiagnosis of focal epilepsy and consequently inappropriate use of narrow spectrum anti-seizure medicine.
Identifiants
pubmed: 35706911
doi: 10.1016/j.ebr.2022.100555
pii: S2589-9864(22)00032-6
pmc: PMC9189997
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100555Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Epilepsia. 2009 Jul;50(7):1827-32
pubmed: 19260942
Epilepsia. 2009 Oct;50(10):2326-9
pubmed: 19785670
Epilepsia. 1997 Jul;38(7):797-812
pubmed: 9579907
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Epilepsy Res. 2021 Feb;170:106547
pubmed: 33421702
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Epilepsia. 2005 Oct;46(10):1668-76
pubmed: 16190941
Epilepsy Behav. 2012 Oct;25(2):277-81
pubmed: 23059065
Semin Pediatr Neurol. 2010 Mar;17(1):39-43
pubmed: 20434692
Epilepsia. 2017 Apr;58(4):531-542
pubmed: 28276064
Epilepsy Behav. 2016 Jan;54:20-9
pubmed: 26619379
Epileptic Disord. 2007 Sep;9(3):307-14
pubmed: 17884755
Epilepsia. 2005;46 Suppl 9:133-9
pubmed: 16302887
Epilepsia. 2014 Aug;55(8):1157-69
pubmed: 24938654